|
|
Comparison of sensitivities of Tumor M2-PK, CEA, CA19-9 and CA 72.4 in gastric tumors nm = non metastasized; m = metastasized; t = total |
![]() |
|
Sensitivities for combination of Tumor M2-PK with classical tumor markers Schulze, 2000: Tumor M2-PK + Ca 72-4: 82 % |
||
|
Tumor M2-PK concentrations were measured with a sandwich ELISA from CEA, CA-19-9 and CA 72-4 were determined using, Cobras Core II from Roche Diagnostics, Mannheim, enzymun Test-ES 600 Immunology Multianalyzer as well as tests from Sorin Diagnostics, Saluggia. |
||
|
Tumor M2-PK: clinical relevance for metabolic profiling of tumors |
||
